Market Value1,686,022,983
Total Holdings46
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PFE / Pfizer Inc. Call
ORIC / ORIC Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
SRPT / Sarepta Therapeutics, Inc.
MTSR / Metsera, Inc.
DYN / Dyne Therapeutics, Inc.
CRGX / CARGO Therapeutics, Inc.
MBX / MBX Biosciences, Inc.
TECX / Tectonic Therapeutic, Inc.
PRME / Prime Medicine, Inc.
NGNE / Neurogene Inc.
ETON / Eton Pharmaceuticals, Inc. Call
TNGX / Tango Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ATRA / Atara Biotherapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
REPL / Replimune Group, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
KROS / Keros Therapeutics, Inc.
PRTA / Prothena Corporation plc
JANX / Janux Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
IMNM / Immunome, Inc.
ARVN / Arvinas, Inc.
AVIR / Atea Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
WHWK / Whitehawk Therapeutics, Inc.
DNA / Ginkgo Bioworks Holdings, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
UPB / Upstream Bio, Inc.
HOOK / HOOKIPA Pharma Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
VERV / Verve Therapeutics, Inc.
ETON / Eton Pharmaceuticals, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
RLAY / Relay Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
XNCR / Xencor, Inc.
VYGR / Voyager Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
MLTX / MoonLake Immunotherapeutics
ALVR / AlloVir, Inc.
ARTV / Artiva Biotherapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc. Call
THRD / Third Harmonic Bio, Inc.
SWTX / SpringWorks Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
GBIO / Generation Bio Co.
QURE / uniQure N.V. Call
QURE / uniQure N.V.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
BEAM / Beam Therapeutics Inc.
CRSP / CRISPR Therapeutics AG
KLRS / Kalaris Therapeutics, Inc.
KURA / Kura Oncology, Inc.
ZYME / Zymeworks Inc.
TCRX / TScan Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.